相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PON1 55 and 192 Gene Polymorphisms in Type 2 Diabetes Mellitus Patients in a Turkish Population
Mehmet Ali Ergun et al.
BIOCHEMICAL GENETICS (2011)
Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on
Lucio G. Costa et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis
Alejandro Gugliucci et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population
Nidhi Gupta et al.
GENE (2011)
HOW DO APOLIPOPROTEINS ApoB AND ApoA-I PERFORM IN PATIENTS WITH ACUTE CORONARY SYNDROMES
Grazyna Sypniewska et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2011)
Paraoxonase 1 (PON1) Polymorphisms, Haplotypes and Activity in Predicting CAD Risk in North-West Indian Punjabis
Nidhi Gupta et al.
PLOS ONE (2011)
The relationship of PON1 QR 192 and LM 55 polymorphisms with serum paraoxonase activities of Turkish diabetic patients
Durdu Altuner et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2011)
The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease
Randa H. Mohamed et al.
CLINICAL BIOCHEMISTRY (2010)
Effect of non-genetic factors on paraoxonase 1 activity in patients undergoing hemodialysis
Marija Grdic Rajkovic et al.
CLINICAL BIOCHEMISTRY (2010)
GHRELIN, NITRITE AND PARAOXONASE/ARYLESTERASE CONCENTRATIONS IN CEMENT PLANT WORKERS
Suleyman Aydin et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2010)
The Effect of Grape Seed Extracts on Serum Paraoxonase Activities in Streptozotocin-Induced Diabetic Rats
Aysel Kiyici et al.
JOURNAL OF MEDICINAL FOOD (2010)
Dietary Blueberries Attenuate Atherosclerosis in Apolipoprotein E-Deficient Mice by Upregulating Antioxidant Enzyme Expression
Xianli Wu et al.
JOURNAL OF NUTRITION (2010)
Molecular Staging of Epithelial Maturation Using Secretory Cell-Specific Genes as Markers
Anna C. Zemke et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Paraoxonase activity against nerve gases measured by capillary electrophoresis and characterization of human serum paraoxonase (PON1) polymorphism in the coding region (Q192R)
Mieko Kanamori-Kataoka et al.
ANALYTICAL BIOCHEMISTRY (2009)
Paraoxonases role in the prevention of cardiovascular diseases
Mira Rosenblat et al.
BIOFACTORS (2009)
Serum lipid profile paraoxonase and arylesterase activities in psoriasis
Aysun Toker et al.
CELL BIOCHEMISTRY AND FUNCTION (2009)
Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment
Abdullah Onder Barim et al.
CLINICAL BIOCHEMISTRY (2009)
The paraoxonase gene family and atherosclerosis
David Seo et al.
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology
Valerie Leduc et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Resveratrol supplementation worsen the dysregulation of genes involved in hepatic lipid homeostasis observed in hyperhomocysteinemic mice
Christophe Noll et al.
FOOD AND CHEMICAL TOXICOLOGY (2009)
Paraoxonase-1 Status in Crohn's Disease and Ulcerative Colitis
Dorota Boehm et al.
INFLAMMATORY BOWEL DISEASES (2009)
Paraoxonase Gene Polymorphism in South-western Korean Population
Byoung-Soo Shin
JOURNAL OF KOREAN MEDICAL SCIENCE (2009)
Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice
Christophe Noll et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
Paraoxonase Variants Relate to 10-Year Risk in Coronary Artery Disease Impact of a High-Density Lipoprotein-Bound Antioxidant in Secondary Prevention
Jakub J. Regieli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Paraoxonase activity and dementia
Hanna Wehr et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
GENETIC POLYMORPHISM IN PARAOXONASE 1 (PON1): POPULATION DISTRIBUTION OF PON1 ACTIVITY
Gary Ginsberg et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2009)
Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease
Julien Chapuis et al.
NEUROBIOLOGY OF AGING (2009)
Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study
Rakesh S. Birjmohun et al.
PLOS ONE (2009)
Paraoxonase 1 (PON1) status and substrate hydrolysis
Rebecca J. Richter et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease
Hamid Moradi et al.
TRANSLATIONAL RESEARCH (2009)
Measurement of serum paraoxonase-1 activity in the evaluation of liver function
Jordi Camps et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
PON1 activity and total oxidant status in patients with active pulmonary tuberculosis
Sahbettin Selek et al.
CLINICAL BIOCHEMISTRY (2008)
Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides
M. Mastorikou et al.
DIABETIC MEDICINE (2008)
Interethnic variability of plasma paraoxonase (PON1) activity towards organophosphates and PON1 polymorphisms among Asian populations - A short review
Safiyya Mohamed Ali et al.
INDUSTRIAL HEALTH (2008)
Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: Emphasis on the cholinergic system and beta-amyloid levels
Valerie Leduc et al.
NEURODEGENERATIVE DISEASES (2008)
Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis
M. Aslan et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans
No Soo Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment
Asli Sarandol et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Paraoxonase (PON) 1192R allele carriage is associated with reduced risk of inflammatory bowel disease
Amir Karban et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model
Bilal Ustundag et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Synergistic effects between Q192R polymorphism of paraoxonase I gene and some conventional risk factors in premature coronary artery disease
Anna Balcerzyk et al.
ARCHIVES OF MEDICAL RESEARCH (2007)
PON1 status in haemodialysis patients and the impact of hepatitis C infection
Mehmet Horoz et al.
CLINICAL BIOCHEMISTRY (2007)
Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice
Diana M. Shih et al.
CIRCULATION RESEARCH (2007)
Oxidative status and serum PON1 activity in beta-thalassemia minor
Sahbettin Selek et al.
CLINICAL BIOCHEMISTRY (2007)
Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients
Noppawan Phumala Morales et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
Association analysis of the paraoxonase-1 gene with Alzheimer's disease
Elena Cellini et al.
NEUROSCIENCE LETTERS (2006)
Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes
Chang Yeop Han et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis
Gulden Baskol et al.
CELL BIOCHEMISTRY AND FUNCTION (2006)
Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydyl groups
L Jaouad et al.
ATHEROSCLEROSIS (2006)
Distribution of paraoxonase PON1 gene polymorphisms in Mexican populations.: Its role in the lipid profile
R Gamboa et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2006)
Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure
A Ece et al.
PEDIATRIC NEPHROLOGY (2006)
Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II nutrition cohort
Victoria L. Stevens et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Serum arylesterase and paraoxonase activity in patients with chronic hepatitis
Suleyman Sirri Kilic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Effects of green tea on serum paraoxonase/arylesterase activities in streptozotocin-induced diabetic rats
S Tas et al.
NUTRITION RESEARCH (2005)
Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease
N Martinelli et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2005)
Modulation of paraoxonase (PON1) activity
LG Costa et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus
B Agachan et al.
CELL BIOCHEMISTRY AND FUNCTION (2004)
Paraoxonase 1 gene polymorphisms and dementia in humans
N Helbecque et al.
NEUROSCIENCE LETTERS (2004)
PON1 M/L55 mutation protects high-risk patients against coronary artery disease
SA Oliveira et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2004)
Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population
J Clarimon et al.
NEUROSCIENCE LETTERS (2004)
Ghrelin degradation by serum and tissue homogenates: Identification of the cleavage sites
C De Vriese et al.
ENDOCRINOLOGY (2004)
Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1
SP Deakin et al.
CLINICAL SCIENCE (2004)
The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients
S Campo et al.
CLINICAL BIOCHEMISTRY (2004)
Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties
L Rodrigo et al.
BIOCHEMICAL JOURNAL (2003)
Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-10 and tumor necrosis factor-α, but is upregulated by interleukin-6
Y Kumon et al.
LIFE SCIENCES (2003)
Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response
VG Cabana et al.
JOURNAL OF LIPID RESEARCH (2003)
Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus
S Kopprasch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase
NJ Beaumont et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women
G Fortunato et al.
ATHEROSCLEROSIS (2003)
Paraoxonas (PON1) as a biomarker of susceptibility for organophosphate toxicity
LG Costa et al.
BIOMARKERS (2003)
Lack of association between Alzheimer's disease and Gln-Arg 192 Q/R polymorphism of the PON-1 gene in an Italian population
R Pola et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevated HDLs
A Gnasso et al.
ATHEROSCLEROSIS (2002)
Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia
G Paragh et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2002)
Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activity
G Ferretti et al.
ACTA DIABETOLOGICA (2001)
Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein
CJ Ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue.: implications for its physiological role
L Rodrigo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2001)
Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus
O Kordonouri et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Hydrolysis of platelet-activating factor by human serum paraoxonase
L Rodrigo et al.
BIOCHEMICAL JOURNAL (2001)
Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation
DI Draganov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
How high-density lipoprotein protects against the effects of lipid peroxidation
MI Mackness et al.
CURRENT OPINION IN LIPIDOLOGY (2000)
Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities
M Aviram et al.
CIRCULATION (2000)
Glycation impairs high-density lipoprotein function
CC Hedrick et al.
DIABETOLOGIA (2000)
分享论文
